Genprex, Inc.

Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in developing a new approach to treating cancer based on its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells and modulates the immune response against ca

Recent News

Genprex Featured in NetworkNewsAudio Broadcast on Potential Gene Therapy Treatment for Cancer

New York, New York--(Newsfile Corp. - April 12, 2019) - Genprex Inc. (NASDAQ: GNPX) announces the availability of a NetworkNewsAudio broadcast titled, "Potential Blockbuster Gene Therapy Programs to Watch in 2019."To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/j1WMsTo read the full editorial, visit: http://nnw.fm/YC9iqGenprex already has over 30 issued patents for its platform technologies. The company's promising pipeline currently includes a phase I/II clinical trial

2019-04-12 9:00 AM EDT

Genprex (GNPX) Featured in NetworkNewsWire Publication about Revolutionary Gene Therapies

New York, New York--(Newsfile Corp. - April 11, 2019) - Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.To view the full publication, titled "Potential Blockbuster Gene Therapy Programs to Watch in 2019," visit: http://nnw.fm/YC9iqPerhaps no other disease strikes as much dread and fear as cancer. Many successful treatments are available today that didn't exist just a couple decades ago; however, cancer...

2019-04-11 8:30 AM EDT

Genprex Featured in NetworkNewsAudio Publication on Unprecedented Targeting in Cancer Treatment

New York, New York--(Newsfile Corp. - March 29, 2019) - Genprex Inc. (NASDAQ: GNPX) announces the availability of a NetworkNewsAudio publication titled, "Advanced Medical Technologies Provides Unprecedented Targeting in Cancer Therapy."To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/XRt4dTo read the full editorial, visit: http://nnw.fm/tB7LiA multiplicity of potential breakthrough treatments to fight cancer are in varying stages of clinical development, and many are focused on the promise of advanced gene therapies. Genprex In

2019-03-29 9:00 AM EDT

Genprex Featured in NetworkNewsWire Publication on Innovations in Cancer Therapy

New York, New York--(Newsfile Corp. - March 28, 2019) - Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.To view the full publication, titled "Advanced Medical Technologies Provides Unprecedented Targeting in Cancer Therapy," visit: http://nnw.fm/l3DkVGenprex is on the cusp of potentially delivering life-changing therapeutics for cancer patients by utilizing th

2019-03-28 8:30 AM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us